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Early pregnancy loss incidence in high-
income settings: a protocol for a systematic 
review and meta-analysis
L. Schummers1* , N. Oveisi1,2, M. S. Ohtsuka1,2, J. A. Hutcheon3, K. A. Ahrens4, J. Liauw3 and W. V. Norman1,5 
Abstract 
Background: Early pregnancy loss (unintended pregnancy loss before 20 completed weeks of gestation) is a com-
mon adverse pregnancy outcome, with previous evidence reporting incidence ranging from 10 to 30% of detected 
pregnancies. The objective of this systematic review and meta-analysis is to determine the incidence and range of 
early pregnancy loss in contemporary pregnant populations based on studies with good internal and external valid-
ity. Findings may be useful for clinical counseling in pre-conception and family planning settings and for people who 
experience early pregnancy loss.
Methods: We will search MEDLINE, EMBASE, and CINAHL databases using combinations of medical subject head-
ings and keywords. Peer-reviewed, full-text original research articles that meet the following criteria will be included: 
(1) human study; (2) study designs: controlled clinical trials or observational studies with at least 100 pregnancies in 
the denominator, or systematic reviews of studies using these designs; (3) conducted in high-income countries; (4) 
reporting early pregnancy loss incidence, defined as unintended early pregnancy loss occurring prior to 20 weeks’ 
gestation expressed as the number of losses among all pregnancies in the study period; (5) among a contemporary 
(1990 or later) general population of pregnancies; and (6) published between January 1, 1990, and August 31, 2021. 
We will assess the quality of included studies according to the United States Preventive Services Task Force Criteria 
for Assessing Internal and External Validity of Individual Studies. If appropriate, based on methodological compara-
bility across included studies, we will conduct meta-analyses using random effects models to estimate the pooled 
incidence of early pregnancy loss among all studies with both good internal and external validity, with meta-analyses 
stratified by study design type (survey-based or self-reported and medical record-based), by induced abortion restric-
tions (restricted vs. unrestricted), and by gestational age (first trimester only vs. all gestational ages before 20 weeks).
Discussion: This systematic review will synthesize existing evidence to calculate a current estimate of early preg-
nancy loss incidence and variability in reported incidence estimates in high-income settings. The findings of this 
review may inform updates to clinical counseling in pre-conception and family planning settings, as well as for 
patients experiencing early pregnancy loss.
Systematic review registration: We have registered this review with the International Prospective Register of Sys-
tematic Reviews (PROSPERO # 226267).
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Background
Early pregnancy loss (unintended pregnancy loss before 
20 completed weeks of gestation) is a common adverse 
pregnancy outcome, with reported incidence rang-
ing from 10 to 30% of detected pregnancies [1–3]. Early 
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pregnancy loss spans a range of subtypes, including spon-
taneous abortion, missed abortion, incomplete abortion, 
molar pregnancy, and others. Current clinical practice 
guidelines on early pregnancy loss diagnosis and man-
agement published by the American College of Obstetri-
cians and Gynecologists (ACOG) and the UK’s National 
Institute for Health and Care Excellence (NICE) cite 
incidence estimates of 10% [4] and 20% [5], respectively 
[2, 6, 7]. The estimates are drawn from small (n < 600), 
highly selected clinical cohort studies conducted in the 
1980s–1990s [1–3]. These estimates may not be applica-
ble to general pregnant populations due to the selection 
of predominantly white and college-educated pregnant 
people with a planned pregnancy. With many changes in 
the characteristics of pregnant populations in the past 30 
years (particularly increased frequency of delayed child-
bearing [8], assisted reproductive technology utilization 
[9], and pregnancies to persons with comorbidities such 
as obesity, diabetes mellitus, or hypertension [10–12]), 
the incidence of early pregnancy loss reported in studies 
before 1990 may not be generalizable to contemporary 
populations.
Furthermore, these commonly cited estimates of early 
pregnancy loss incidence may not be applicable to clini-
cal counseling in most settings. This is because these 
estimates are based on the detection of pregnancy and 
early pregnancy loss within studies with specific research 
protocols [1, 3] that are unlikely to be replicated in stand-
ard pregnancy experience and care outside of research 
settings. These studies collected prospective, serial 
beta-human chorionic gonadotropin measurements to 
identify pregnancies and losses. Outside of research set-
tings, pregnancy identification is based on pregnancy 
symptoms or pregnancy tests conducted at home or at a 
health care visit at approximately 5–6 weeks of gestation, 
with 23–28% of pregnancies being identified ≥7 weeks’ 
gestation. For clinical counseling purposes, determining 
the incidence of early pregnancy loss among pregnan-
cies identified in non-research settings is more relevant 
because this reflects the risk for standard patients [13, 
14].
Estimates of early pregnancy loss among pregnancies 
identified in non-research settings can be obtained from 
several sources, including population-based adminis-
trative databases (e.g., pregnancy registries created by 
abstracting from medical records and/or billing claims 
data based on clinical pregnancy care) and reproductive 
health surveys (e.g., routinely administered nationally 
representative reproductive health surveys such as the 
National Survey of Family Growth [15], from the USA, 
or the National Survey of Sexual Attitudes and Lifestyles 
[16] from the UK). Population-based administrative data-
base studies have yielded early pregnancy loss incidence 
estimates ranging from 12% [17] to 17% [18], while sur-
veys have yielded estimates from 18% [19] to 24% [10]. 
These population-based estimates may better approxi-
mate clinically relevant measures of early pregnancy loss 
incidence than those drawn from highly selected clinical 
cohorts.
The objective of this systematic review is to determine 
the incidence and range of early pregnancy loss in con-
temporary pregnant populations based on studies with 
good internal and external validity. Findings may be use-
ful for clinical counseling in pre-conception and family 
planning settings and for people experiencing early preg-
nancy loss [20–22].
Methods
The design and implementation of this systematic review 
will adhere to the Preferred Reporting Items for Sys-
tematic Review and Meta-Analysis Protocols (PRISMA-
P) 2015 statement [23]. We have registered this review 
with the International Prospective Register of Systematic 
Reviews (PROSPERO) (systematic review identification 
number 226267). This study was deemed exempt from 
ethics review from the University of British Columbia 
and Children’s and Women’s Health Centre of British 
Columbia Research Ethics Board.
The key question underlying this systematic review is: 
“What is the incidence of early pregnancy loss in contem-
porary general pregnant populations in high-income set-
tings?” We will approach this question using the modified 
PICOT framework [24] outlined in Table 1.
Data sources and search strategy
We will search MEDLINE, EMBASE, and CINAHL data-
bases, using a search strategy developed in consultation 
with a research librarian (see Additional file  1: Search 
Strategy) using relevant medical subject headings and 
keywords. We piloted the search strategy for each data-
base using a list of 17 papers that we identified a priori 
as meeting our intended inclusion criteria; we revised 
our search strategy to minimize the number of abstracts 
that would need to be reviewed while capturing these 
key papers in our search (Table 2). We will augment this 
search strategy by hand-searching the bibliographies of 
eligible studies meeting inclusion criteria for additional 
relevant articles not identified in our database search 
and a preliminary gray literature key-word search using 
Google (for relevant newspaper articles, retracted pub-
lications, and other publications from relevant stake-
holders) and gray literature databases (OpenGrey, TRIP 
Pro, New York Academy of Medicine’s Grey Literature 
Report, and Canadian Institute for Health Information). 
We will review and evaluate gray literature using the 
same criteria as the peer-reviewed literature.
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Eligibility criteria
Peer-reviewed, full-text original research articles that 
meet all of the following inclusion criteria will be 
included in this review: (1) human study; (2) study 
designs: controlled clinical trials or observational stud-
ies (prospective cohort, retrospective cohort, cross-sec-
tional, chart review, survey) with at least 100 pregnancies 
in the denominator, or systematic reviews of studies using 
these designs; (3) conducted in high-income countries (as 
defined by the World Bank; “High-Income OECD Coun-
tries” [25]); (4) reporting early pregnancy loss incidence, 
defined as unintended early pregnancy loss occurring 
prior to 20 weeks’ gestation expressed as the number of 
losses identified in typical practice settings (i.e., not spe-
cific research settings) among all pregnancies in the study 
period; (5) among a contemporary (1990 or later) general 
population of pregnancies; (6) published between Janu-
ary 1, 1990, and August 31, 2021. Studies meeting at least 
one of the following exclusion criteria will be excluded: 
(1) non-human study; (2) controlled clinical trials or 
observational studies with fewer than 100 pregnan-
cies in the denominator, studies using any other designs 
(case-control, case reports or series, editorials, opinions, 
commentaries, or other designs not specified in inclu-
sion criteria); (3) conducted outside OECD high-income 
setting; (4) not reporting early pregnancy loss incidence; 
(5) study population not contemporary (including preg-
nancies exclusively before January 1, 1990); (6) study 
population restricted to assisted reproductive technology 
setting; (7) study population sampled using any sampling 
method (e.g., restriction, oversampling, case-control) 
based on a clinical condition or characteristic, defined as 
any condition, disease, or characteristic with a diagno-
sis code, treatment with a specific medication or proce-
dure, or recruitment from a specialty clinic serving those 
with a specific disease or condition. Studies that selected 
the study population based on age, body mass index, or 
other social, demographic, or environmental characteris-
tics will not be excluded under this criterion; (8) studies 
reporting only uncommon types of early pregnancy loss 
Table 1 Modified PICOT chart outlining the framework underlying this systematic review of the literature reporting early pregnancy 
loss incidence
Because this systematic review is not evaluating a specific intervention or exposure, our PICOT framework does not include an intervention or comparator 
components
OECD Organization for Economic Cooperation and Development
Included Excluded
Population All recognized pregnancies, defined by either self-report or report 
to a health care provider or indicated by a pregnancy-related clini-
cal encounter, in OECD-classified high-income settings, represent-
ing general pregnant populations.
Pregnancies not recognized by the pregnant 
person or pregnancies occurring in a setting 
not classified as high-income by OECD; study 
populations restricted to assisted reproductive 
technology settings
Outcome Early pregnancy loss, defined as unintended pregnancy loss occur-
ring prior to 20 weeks’ gestation expressed as the number of losses 
among all pregnancies in the study period, including all types of 
unintended pregnancy loss occurring before 20 weeks of gesta-
tion or only common types of early pregnancy loss (spontaneous, 
missed, incomplete abortions only)
Induced abortion, stillbirth (intrauterine fetal 
demise after 20 completed weeks of gestation), 
and less common subtypes of early pregnancy 
loss examined separately (hydatidiform mole/
molar pregnancy, anembryonic pregnancy, 
ectopic pregnancy)
Time Jan 1, 1990–August 31, 2021 Before Jan 1, 1990, or after August 31, 2021
Table 2 Search strategy summary for a systematic review of early pregnancy loss in high-income settings
Keywords
Early pregnancy loss*, spontaneous abortion*, miscarriage*, fetal loss*, pregnancy loss*, anembryonic pregnanc*, embryonic loss*, 
spontaneous miscarriage*, early pregnancy failure*, pregnancy failure*, hydatidiform mole, septic abortion*, missed abortion*, 
incomplete abortion*, ectopic pregnanc*, risk*, rate*,  prevalen*, inciden*, report*, trend*, impact*Keywords terms for high-income 
countries (as defined by World Bank; “High-Income OECD Countries”25) (see Additional file 1: Search Strategy).
Database-specific subject headings
 MEDLINE Subject heading (MeSH): Spontaneous abortion, septic abortion, missed abortion, incomplete abortion, ectopic pregnancy, , 
hydatidiform mole, risk, morbidity, incidence, prevalence. MeSH terms for high-income countries (as defined by World Bank; “High 
Income OECD Countries”25) (see Additional file 1: Search Strategy).
 CINAHL Subject heading: Spontaneous abortion, incomplete abortion, hydatidiform mole, ectopic pregnancy, incidence, prevalence, mor-
bidity.
 EMBASE Subject heading (Emtree): Spontaneous abortion, septic abortion, incomplete abortion, missed abortion, blighted ovum, hydatidi-
form mole, risk, morbidity, incidence, prevalence. Emtree terms for high-income countries (as defined by World Bank; “High-Income 
OECD Countries”25) (see Additional file 1: Search Strategy).
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(ectopic pregnancy, molar pregnancy, hydatidiform mole, 
anembryonic pregnancy); and (9) published before Janu-
ary 1, 1990, or after August 31, 2021.
To prevent publication bias arising from restriction to 
studies published in English [26], we will include studies 
published in languages other than English using transla-
tion services at our University or Google Translate.
In settings where induced abortion services were 
restricted by law or strict regulations, induced abortions 
may be erroneously reported as early pregnancy loss 
[27]. Because the legal status and availability of induced 
abortion services vary by setting (even within OECD 
high-income countries), we will categorize included 
studies based on whether induced abortion access was 
“restricted” vs. “unrestricted” using classifications pub-
lished yearly by the Centre for Reproductive Rights [28] 
(see Additional file 2: Induced abortion regulation classi-
fication). This will allow us to examine whether reported 
early pregnancy loss incidence varies by induced abor-
tion regulatory status (by examining incidence separately 
among studies in settings with restricted and unrestricted 
induced abortion access at the time of study data collec-
tion). In the event that reported incidence estimates do 
vary meaningfully, we will conduct a quantitative bias 
analysis to account for misclassification of induced abor-
tions as early pregnancy losses [29].
Study selection and data management
Two reviewers (NO, MO) will independently dual-screen 
titles and abstracts for eligibility and will review full texts 
of studies that were screened and determined to not meet 
at least one exclusion criterion. Any discrepancies will be 
discussed until consensus is reached. A third reviewer 
(LS, doctoral-level reproductive epidemiologist) will also 
review a random selection of 50 abstracts against inclu-
sion/exclusion criteria and will discuss with the two pri-
mary reviewers, provide any training required, adjudicate 
to resolve any discrepancies for the remaining abstracts, 
and oversee the full-text reviews. We will import all eli-
gible articles from the primary search into an Endnote 
library, then to the Covidence platform for systematic 
reviews [30]. We will remove duplicates using Covidence. 
The first reason for exclusion will be documented in Cov-
idence based on our PICOT framework using this hierar-
chy: (1) population not meeting our eligibility criteria, (2) 
outcome definition not meeting our eligibility criteria, or 
(3) time outside our eligibility window.
The two reviewers will extract study details and find-
ings using standardized data extraction forms (see Addi-
tional file  3: Data Extraction Form). Extracted data will 
include author and year published, study setting (includ-
ing induced abortion restriction classification) [31], 
study period, study design, sample size, early pregnancy 
loss incidence (numerator n, denominator n, percent-
age, and standard error), specific early pregnancy loss 
type(s) studied with definitions, subgroups examined, 
exposure(s)/risk factors examined, and gestational age 
range and distribution for early pregnancy losses. See 
Table 3 for characteristics to be extracted.
Quality assessment
Two reviewers (NO and MO) will independently evaluate 
and rate the quality of the included studies according to 
the United States Preventive Services Task Force, Criteria 
for Assessing Internal and External Validity of Individual 
Studies [32]. To finalize the quality assessment ratings, 
the two reviewers and senior reviewer (LS) will meet to 
discuss until consensus is reached on the quality rating 
for internal and external validity for all included stud-
ies. We will rate the internal validity of included studies 
as “good,” “fair,” or “poor” based on these criteria. We 
will evaluate internal validity according to information 
bias (studies must clearly and appropriately define early 
pregnancy loss and total pregnancies; studies that only 
include inpatient hospitalization data will have a maxi-
mum rating of “fair”) and selection bias (study sample 
should be representative of those eligible for inclusion, or 
the study base; loss to follow-up should be less than 20% 
for a “good” internal validity rating). Since our review will 
examine reported estimates of early pregnancy loss, but 
not associations with specified exposures, the impor-
tance of confounding bias is minimal in this review. For 
a study to be rated as having “good” internal validity, it 
must meet all study design-specific criteria, as laid out by 
United States Preventive Services Task Force. If a study 
misses at least one criterion, it will be rated “fair.” If a 
study has important limitations or a fatal methodologi-
cal flaw, it will be rated “poor.” External validity assess-
ment is rated as “poor,” “fair,” or “good” and will focus on 
the generalizability of findings to underlying regional or 
Table 3 Characteristics of included studies reporting early pregnancy loss incidence in high-income settings
Page 5 of 7Schummers et al. Syst Rev          (2021) 10:274  
national populations. Our assessment of external valid-
ity will consider the similarity of the regional or national 
population being represented to the general obstetric 
population of high-income settings (the target popula-
tion for this review). For example, a maximum external 
validity rating of “good” would require the study popu-
lation to be the full population or employ representa-
tive sampling from the full population of pregnancies 
in an OECD high-income country or large region (e.g., 
state or province, multiple counties or cities); restriction 
to one city or county would result in a maximum exter-
nal validity rating of “fair”; restriction to one hospital/
clinic, region, or sample characteristic (e.g., occupation, 
racial/ethnic group) would result in a maximum external 
validity rating of “poor”. Likewise, a maximum external 
validity rating of “good” requires that the age range use 
the full reproductive age range (or at least ages 18–44), 
while restriction to an age range of more than 10 years 
would result in an external validity rating of “fair,” and 
restriction to an age range <10 years would result in a rat-
ing of “poor.” External validity ratings will also consider 
pregnancy detection methods that do not apply in stand-
ard clinical or at-home pregnancy detection settings. If 
a study population is restricted by marital status (e.g., 
only married people), pregnancy intention (e.g., only 
planned pregnancies), or pregnancy history (e.g., par-
ity or loss), the maximum external validity rating will be 
“fair.” For survey studies, we will report response rates, 
which are an important component of external valid-
ity for this study design. See Table  4  for a drafted table 
showing reported incidence and quality assessments. See 
Additional file 4: Quality Assessment Rationale for crite-
ria that will be used in rating study internal and external 
validity.
Meta‑analysis
If deemed appropriate, based on methodological compa-
rability across included studies, we will conduct a quan-
titative meta-analysis of early pregnancy loss incidence 
to combine estimates from all studies with good internal 
and external validity. We will present incidence estimates 
from individual studies included in the meta-analysis 
along with the pooled incidence from the meta-analysis 
(Table  5). We will conduct the meta-analysis using ran-
dom effects models with inverse-variance weighting 
using the Hartung-Knapp-Sidik-Jonkman method to 
estimate an average incidence value for early pregnancy 
loss across studies; this method is robust to biases that 
can arise due to a small number of included studies or 
variability in sample size across studies [33]. We will 
assess heterogeneity among included studies according 
to (i) overlap of confidence intervals around estimated 
incidence values, (ii) the I2 statistic (a quantification of 
inconsistency among studies, indicating the proportion 
of variability across studies that is due to heterogeneity), 
(iii) and the  Tau2 statistic (τ2, a measure of between-study 
variance). We will consider an I2 value < 25% to indi-
cate non-important heterogeneity, 25–<50% to indicate 
modest heterogeneity, 50–<75% to indicate substantial 
heterogeneity, and ≥75% to indicate considerable het-
erogeneity [34]. In addition, we will calculate a 90% 
prediction interval around our overall early pregnancy 
loss incidence estimate, which provides a measure of 
dispersion or variability in incidence values from the 
underlying populations from which study cohorts were 
drawn [35].
We will conduct meta-analyses stratified by gesta-
tional age (first trimester only vs. all gestational ages 
before 20 weeks) and study design type (administrative 
data derived from medical records vs. survey or patient-
reported data) and by induced abortion restrictions 
(restricted vs. unrestricted). We will examine hetero-
geneity within strata of the stratified analysis to deter-
mine if accounting for the clinical and methodological 
sources of heterogeneity that we identified a priori are 
sufficient to account for any important observed hetero-
geneity. We will conduct all meta-analyses using Stata 
14.0.
Table 4 Incidence of early pregnancy loss and quality assessment for studies included in the systemic review
Table 5 Incidence of early pregnancy loss in high-income settings, meta-analysis findings
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Discussion
This systematic review will examine the incidence of 
early pregnancy loss among contemporary populations 
in high-income settings. This review will provide the best 
available evidence regarding early pregnancy loss inci-
dence and the range of incidence values. We will deter-
mine variability in reported incidence by study design, 
induced abortion legal status, and gestational age for 
early pregnancy losses and summarize these findings 
using meta-analysis.
Findings of this systematic review and meta-analysis will 
need to be interpreted in light of potential limitations. Early 
pregnancy loss includes a range of subtypes, which may 
be etiologically heterogeneous. By combining these sub-
types, this review will not determine the incidence of each 
type of early loss separately and will specifically exclude 
studies focused only on rare subtypes. The expected data 
sources include data extracted from medical records (e.g., 
using health administrative data) and self-reported data 
(e.g., from survey studies), which can generate estimates 
subject to early pregnancy loss misclassification. Although 
our bias analysis will specifically account for induced abor-
tions being misclassified as pregnancy losses, there may be 
further misclassification (e.g., stillbirths occurring after 20 
weeks of gestation misclassified as an early pregnancy loss), 
which we will not account for analytically.
Pre-conception and family planning clinical counseling, 
as well as clinical care for patients experiencing early preg-
nancy loss, should include current information on the best 
available estimates of early pregnancy loss risk. Given that 
current obstetrics clinical practice guidelines related to 
early pregnancy loss care report incidence based on highly 
selected populations published 20–30 years ago, clinical 
counseling may not reflect the best available evidence on 
this incidence of this common adverse pregnancy outcome.
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